What are the normal ranges for prothrombin time (PT), activated partial thromboplastin time (APTT), and international normalized ratio (INR), when is each abnormal result clinically significant, and which medication is used to reverse each abnormality?

Normal Ranges and Clinical Significance of Coagulation Tests

For PT, the normal range is approximately 11-13.5 seconds with an INR of 0.8-1.2; for APTT, normal is approximately 25-35 seconds; elevated PT/INR is corrected with vitamin K (for warfarin reversal) or fresh frozen plasma/prothrombin complex concentrate (for acute bleeding), while elevated APTT is corrected with fresh frozen plasma or specific factor replacement depending on the underlying deficiency.

Normal Reference Ranges

Prothrombin Time (PT)

• Normal PT: 11-13.5 seconds (may vary slightly by laboratory)
• The PT measures the extrinsic and common coagulation pathways (factors VII, X, V, II, and fibrinogen)

International Normalized Ratio (INR)

• Normal INR: 0.8-1.2
• The INR standardizes PT results across different laboratories and thromboplastin reagents 1
• Therapeutic INR for warfarin therapy: typically 2.0-3.0 (or 2.5-3.5 for mechanical heart valves) 1
• The INR is calculated as: INR = (patient PT/mean normal PT)^ISI, where ISI is the International Sensitivity Index of the thromboplastin reagent 1

Activated Partial Thromboplastin Time (APTT)

• Normal APTT: 25-35 seconds (laboratory-specific; some labs use up to 30 seconds as upper limit) 2
• The APTT measures the intrinsic and common coagulation pathways (factors XII, XI, IX, VIII, X, V, II, and fibrinogen)
• Therapeutic APTT for heparin: 1.5-2.5 times control (or anti-Xa level 0.35-0.70 IU/mL) 3

Clinical Significance of Abnormal Results

When PT/INR is Significantly Elevated

PT > 13.5 seconds or INR > 1.2 warrants investigation, though clinical significance depends on context:

• Warfarin therapy monitoring: INR is the gold standard for monitoring vitamin K antagonists 1
• Liver disease: INR reliably measures impaired coagulation in hepatic dysfunction 1
• Vitamin K deficiency: Malabsorption, malnutrition, or antibiotic use
• Factor VII deficiency: Isolated PT prolongation with normal APTT 4
• Preoperative bleeding risk: PT shows weak association with bleeding in most surgeries, but may predict bleeding in patients with advanced liver disease undergoing major abdominal procedures 5

Critical threshold: While laboratory cutoffs exist, research suggests PT > 13.0 seconds has poor predictive value for inherited bleeding disorders (AUC < 0.6) 2

When APTT is Significantly Elevated

APTT > 35 seconds (or > 30 seconds in some labs) requires evaluation:

• Heparin therapy: Monitoring unfractionated heparin anticoagulation 3
• Hemophilia A or B: Factor VIII or IX deficiency
• von Willebrand disease: Severe forms
• Factor XI, XII deficiency: Less common intrinsic pathway defects
• Lupus anticoagulant: Prolongs APTT but usually causes only slight PT prolongation 1

Critical threshold: Research indicates APTT > 31.4 seconds is associated with inherited bleeding disorders (AUC > 0.8), with even greater specificity at APTT > 33.1 seconds 2

Reversal Agents for Abnormal Coagulation Tests

For Elevated PT/INR (Warfarin Effect or Vitamin K Deficiency)

Vitamin K (phytonadione) is the primary reversal agent:

• Non-urgent correction: Oral vitamin K 2.5-5 mg
• Urgent correction with minor bleeding: IV vitamin K 5-10 mg (onset 12-24 hours)
• Life-threatening bleeding:
  • Four-factor prothrombin complex concentrate (PCC) 25-50 units/kg IV (immediate effect) PLUS vitamin K 10 mg IV
  • Fresh frozen plasma (FFP) 10-15 mL/kg if PCC unavailable (less effective, requires larger volumes)

The INR should normalize within 12-24 hours with vitamin K alone, or immediately with PCC 1

For Elevated APTT (Heparin Effect or Factor Deficiency)

Protamine sulfate for heparin reversal:

• Unfractionated heparin: Protamine 1 mg per 100 units of heparin given in the last 2-3 hours (maximum 50 mg)
• Low molecular weight heparin: Protamine partially effective (60-75% reversal)

For factor deficiencies causing elevated APTT:

• Fresh frozen plasma (FFP): 10-15 mL/kg for multiple factor deficiencies
• Specific factor concentrates:
  • Factor VIII concentrate for hemophilia A
  • Factor IX concentrate for hemophilia B
  • Desmopressin (DDAVP) for mild hemophilia A or von Willebrand disease

For lupus anticoagulant: No reversal needed as it does not cause bleeding; alternative monitoring methods may be required 1

Common Pitfalls and Caveats

• INR unreliability: The INR is less reliable early in warfarin therapy (first 6 weeks) and with lupus anticoagulants, though still more reliable than unconverted PT ratio 1
• Sample collection errors: Underfilled citrate tubes spuriously prolong PT/APTT; use 3.2% citrate tubes to minimize this 1
• Preoperative screening: Routine PT/APTT testing has poor predictive value for bleeding in most elective surgeries and should not replace targeted history-taking 6, 5
• Laboratory variability: Different thromboplastins and coagulometers produce different results despite ISI standardization 7, 8
• Sample rejection: Approximately 15-16% of coagulation samples are rejected due to collection errors, and many patients are not retested 2